Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q1 2021 · 10-Q
Revenue$512.40M$512.40M+16.2% vs Q1 2020 Net Income-$21.00M-$21.00MN/M vs Q1 2020 EPS Diluted-$0.57-$0.57N/M vs Q1 2020 Operating Income$64,300,000+173.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
Free Cash Flowderived$35,700,000+105.2% Margins · derivedOperating margin12.5%+7.2 pt vs Q1 2020
Net margin-4.1%+2.1 pt vs Q1 2020
ended Mar 31, 2021 · filed May 5, 2021 · 35 d after period end